LIVER CANCER
Clinical trials for LIVER CANCER explained in plain language.
Never miss a new study
Get alerted when new LIVER CANCER trials appear
Sign up with your email to follow new studies for LIVER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Seek-and-Destroy' radiation therapy tested for tough liver cancer
Disease control Not yet recruitingThis study is testing a new, targeted radiation treatment for people with advanced liver cancer that has spread. The treatment uses a drug that seeks out cancer cells by attaching to a specific protein (PSMA) found on their blood vessels. Researchers want to see if this approach …
Matched conditions: LIVER CANCER
Phase: PHASE2 • Sponsor: Melissa Lumish • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New cell therapy trial opens for Tough-to-Treat cancers
Disease control Not yet recruitingThis early-stage study is testing a new cell-based treatment called SL-28 in adults with advanced solid tumors that have not responded to standard therapies. The main goals are to find the safest and most effective dose and to check for side effects. Participants will receive the…
Matched conditions: LIVER CANCER
Phase: PHASE1, PHASE2 • Sponsor: Second Life Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC
-
Gene test race: can early screening unlock new cancer treatments?
Disease control Not yet recruitingThis study aims to see if performing a broad genetic test on tumors early in treatment, rather than later, helps find more personalized treatment options for people with advanced pancreatic, liver, or triple-negative breast cancer. It will compare two approaches: one group gets t…
Matched conditions: LIVER CANCER
Phase: NA • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
New drug combo aims to extend life for advanced liver cancer patients
Disease control Not yet recruitingThis study is for people with advanced liver cancer who are already receiving durvalumab after initial treatment with tremelimumab and durvalumab. Researchers want to see if adding an experimental oral drug called zanzalintinib to the ongoing durvalumab treatment helps people liv…
Matched conditions: LIVER CANCER
Phase: PHASE2 • Sponsor: Amit Mahipal • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC
-
3D liver maps aim to make cancer surgery safer
Diagnosis Not yet recruitingThis study is testing whether a new 3D modeling technique can help surgeons better plan liver cancer operations. Researchers will create a personalized 3D map of a patient's liver before surgery and then compare the predicted amount of tissue to be removed with what is actually r…
Matched conditions: LIVER CANCER
Phase: NA • Sponsor: Medical University of Graz • Aim: Diagnosis
Last updated Apr 01, 2026 14:43 UTC